Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://victormfnl505312.pages10.com/trelaglutide-exploring-a-new-option-for-chronic-diseases-74308244